Risk factors of very severe rsv infections in a multicenter cohort of very preterm and extreme preterm babies receiving or not palivizumab

HIGHLIGHTS

• who: Marine Butin from the RMIT University, Australia have published the paper: Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab, in the Journal: (JOURNAL) of 25/02/2022
• what: For the purpose of the present study, the authors focused on infants born before 34 weeks of gestation. The authors explored the risk factors of VS-LRTI in a cohort of 86 ex preterm patients hospitalized for RSV infection during their first year of corrected age. Third, the authors focused on RSV . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.